肺炎克雷伯菌临床分布及耐药特性比较和KPC基因表达分析

中国药物警戒 ›› 2017, Vol. 14 ›› Issue (4): 205-208.

肺炎克雷伯菌临床分布及耐药特性比较和KPC基因表达分析

桂红, 孟凡祥, 洪燕英, 高翔, 崔煦然, 丁军颖, 刘清泉

1.首都医科大学附属北京中医医院,北京 100010;
2 .天津市第四医院,天津 300222

收稿日期:2017-07-05 修回日期:2017-07-05 出版日期:2017-04-20 发布日期:2017-07-05
通讯作者: 刘清泉,男,本科,主任医师,中医药防治急危重症。E-mail：profliu1@163.com
作者简介:桂红,女,本科,主管技师,医学检验。
基金资助:
国家自然科学基金（81503399）：

Clinical Distribution, Drug Resistance Characteristics and KPC Gene Expression Analysis of Klebsiella Pneumonia

GUI Hong, MENG Fan-xiang, HONG Yan-ying, GAO Xiang, CUI Xu-ran, DING Jun-ying, LIU Qing-quan

1.Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, China;
2.Tianjin Fourth Hospital, Tianjin 300222, China

Received:2017-07-05 Revised:2017-07-05 Online:2017-04-20 Published:2017-07-05

摘要/Abstract

摘要： 目的了解肺炎克雷伯菌在不同医院的临床分布及耐药特点,初步分析KPC基因表达状况,为合理选药提供依据。方法分别对两家医院2015年临床送检的所有样本进行病原菌分离鉴定和药敏试验,比较分析样本来源及科室分布特点,并以KB法验证其耐药结果,选出所有耐亚胺培南和美罗培南的菌株,检测其KPC基因的表达状况。结果分别分离出细菌：A院1 694株和B院5 075株,其中肺炎克雷伯菌 A院286株和B院524株;主要分布于重症监护病房和呼吸科;菌株主要源自痰液、尿液和血液样本。耐药率排名A院前五位抗菌药物依次为复方磺胺甲唑、氨苄西林、呋喃妥因、氨苄西林／舒巴坦和哌拉西林;B院前五位抗菌药物依次为复方磺胺甲唑、氨苄西林、呋喃妥因、氨苄西林／舒巴坦和头孢唑啉。耐亚胺培南和美罗培南的菌株,部分表达KPC基因。结论两家医院肺炎克雷伯菌临床科室及标本类型分布特点相近,耐药谱略有差异。提示应以呼吸科和ICU的呼吸道感染作为监测重点,依据耐药基因表达情况合理选择用药。

关键词: 肺炎克雷伯菌, 临床分布特点, 敏感率, 耐药基因

Abstract: Objective To investigate the clinical distribution and drug resistance characteristics of Klebsiella pneumonia in different hospitals, to analyze KPC gene, and to provide the basis for rational drug selection. Methods The pathogenic bacteria were isolated from clinical samples and identified by the two hospitals in 2015 respectively. The sample characteristics in clinical departments and type distribution were investigated. The results about drug resistance were verified with K-B method. All the Klebsiella pneumonia resistant to imipenem and meropenem were selected, of which the KPC genes were detected by PCR. Results The 5075 and 1694 strains bacteria were isolated from two hospitals respectively, including 524 strains Klebsiella pneumoniae and 286 strains respectively, which distributed mainly in ICU and respiratory department and from sputum, urine and blood samples. The drug resistance of Klebsiella pneumoniae in Tianjin Fourth Hospital were compound sulfamethoxazole, ampicillin, nitrofurantoin, ampicillin / sulbactam and piperacillin in order, while those in the other hospital were compound sulfamethoxazole, ampicillin, nitrofurantoin, ampicillin / sulbactam and cefazolin orderly. Some Klebsiella pneumoniae resistant to imipenem and meropenem could express the KPC gene. Conclusion The distribution characteristics and sample types of the two hospitals were similar, and the drug resistance spectrum was slightly different. These indicated that the respiratory tract infection in the respiration department and ICU should be paid attention to, and the rational drug was selected according to the drug resistance gene expression.

Key words: Klebsiella pneumonia, clinical distribution, sensitive rate, drug resistance gene

中图分类号:

桂红¹, 孟凡祥², 洪燕英¹, 高翔¹, 崔煦然¹, 丁军颖¹, 刘清泉^{1*, *}. 肺炎克雷伯菌临床分布及耐药特性比较和KPC基因表达分析[J]. 中国药物警戒, 2017, 14(4): 205-208.

GUI Hong¹, MENG Fan-xiang², HONG Yan-ying¹, GAO Xiang¹, CUI Xu-ran¹, DING Jun-ying¹, LIU Qing-quan^{1, *}. Clinical Distribution, Drug Resistance Characteristics and KPC Gene Expression Analysis of Klebsiella Pneumonia[J]. Chinese Journal of Pharmacovigilance, 2017, 14(4): 205-208.

参考文献

[1] 李静玫, 李海峰, 马萍, 等．PICC置管导致医院感染暴发事件流行病学调查[J]．中华医院感染学杂志, 2010, 20(3):345-347.
[2] Martelius T, Jalava J, Kärki T, et al. Nosocomial bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae resistant to third-generation cephalosporins, Finland, 1999-2013: Trends, patient characteristics and mortality [J]. Infect Dis (Lond), 2016, 48(3): 229-34.
[3] 王辉, 侯万乐, 龚志伟. 医院感染革兰阴性杆菌的分布及耐药性分析[J]．中华医院感染学杂志, 2010, 20(3):414-416.
[4] 国家卫生计生委合理用药专家委员会全国细菌耐药监测网. 2015年全国细菌耐药监测报告[J]. 中国职业医师, 2016, 13(3):3-8.
[5] 李智伟, 韩艳, 莫红梅, 等. 多药耐药肺炎克雷伯菌碳青霉烯酶及整合子检测与分析[J]. 中华医院感染学杂志, 2014, 24(19):4690-4692.
[6] 姚惠, 谢金兰, 秦鮷, 等. 某医院肺炎克雷伯菌医院感染的临床分布及耐药性研究[J]. 中华临床感染病杂志, 2015, 32(6):579-581.
[7] 谢强, 曹明杰, 陈玲, 等. 肺炎克雷伯菌的临床分布与耐药性分析[J]. 中华医院感染学杂志, 2015, 25(17):3854, 3855, 3889.
[8] 张梅, 杜红丽, 刘娜, 等. 2008-2012年河北某医院肺炎克雷伯菌的科室分布及耐药性调查分析[J]．现代预防医学, 2014, 41(3):561-563.
[9] 李慧娟, 周东鹏, 赵楠. 2011-2013年肺炎克雷伯菌的分布与耐药性变迁[J]. 中华医院感染学杂志, 2015, 25(12):2670-2672.
[10] Lee C H, Su L H, Chen F J, et al. Clinical and microbiologic characteristics of adult patients with recurrent bacteraemia caused by extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae. [J]. Clin Microbiol Infect, 2015, 21(12): 1105-1108.
[11] Eftekhar F, Naseh Z. Extended-spectrum β-lactamase and carbapenemase production among burn and non-burn clinical isolates of Klebsiella pneumonia[J]. Iran J Microbiol, 2015, 7(3):144-149.
[12] 吴丹丹, 蔡加昌, 刘进. 耐碳青霉烯肺炎克雷伯菌的感染现状[J]. 中国抗生素杂志, 2011, 36(1):1-6.
[13] Markovska R, Stoeva T, Schneider I, et al. Clonal dissemination of multilocus sequence type ST15 KPC-2-producing Klebsiella pneumoniaein Bulgaria[J]. APMIS, 2015, 123(10): 887-894.
[14] Chan W W, Peirano G, Smyth D J, et al. The characteristics of Klebsiellapneumoniae that produce KPC-2 imported from Greece[J]．Diagn Microbiol Infect Dis, 2013, 75(3): 317-319.
[15] 周秀珍, 李强, 卢岩, 等. 连续12年产超广谱β – 内酰胺酶肺炎克雷伯菌感染分布及耐药性分析[J]．中国微生态学杂志, 2012, 24(2):157-159, 164.
[16] Teo J, Lim T P, Hsu L Y, et al. Extensively drug-resistant Acinetobacter baumannii in a Thai hospital: a molecular epidemiologic analysis and identification of bactericidal Polymyxin B-based combinations[J]. Antimicrob Resist Infect Control, 2015, 4(1): 2.
[17] 翁幸鐾, 糜祖煌. 可移动遗传元件:耐药基因的载体[J]. 中国人兽共患病学报, 2013, 29(4):389-397.
[18] Martínez P, Mattar S. Imipenem-resistant Acinetobacter baumannii carrying the ISAba1-bla OXA-23, 51 and ISAba1-bla ADC-7 genes in Monteria, Colombia[J]. Braz J Microbiol, 2012, 43(4): 1274-1280.